These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 36920298)
41. Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications. Ruscica M; Ferri N; Banach M; Sirtori CR; Corsini A Cardiovasc Res; 2023 Jan; 118(17):3288-3304. PubMed ID: 35238338 [TBL] [Abstract][Full Text] [Related]
42. Prescribing statin therapy in physically (in)active individuals vs prescribing physical activity in statin-treated patients: A four-scenario practical approach. Gavilán-Carrera B; Soriano-Maldonado A; Mediavilla-García JD; Lavie CJ; Vargas-Hitos JA Pharmacol Res; 2023 Nov; 197():106962. PubMed ID: 37866703 [TBL] [Abstract][Full Text] [Related]
43. Statins and cognitive side effects: what cardiologists need to know. Rojas-Fernandez C; Hudani Z; Bittner V Cardiol Clin; 2015 May; 33(2):245-56. PubMed ID: 25939297 [TBL] [Abstract][Full Text] [Related]
44. Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle. Glueck CJ; Abuchaibe C; Wang P Med Hypotheses; 2011 Oct; 77(4):658-61. PubMed ID: 21802861 [TBL] [Abstract][Full Text] [Related]
47. Do the frequencies of adverse events increase, decrease, or stay the same with long-term use of statins? Huddy K; Dhesi P; Thompson PD Curr Atheroscler Rep; 2013 Feb; 15(2):301. PubMed ID: 23299641 [TBL] [Abstract][Full Text] [Related]
48. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP). Penson PE; Bruckert E; Marais D; Reiner Ž; Pirro M; Sahebkar A; Bajraktari G; Mirrakhimov E; Rizzo M; Mikhailidis DP; Sachinidis A; Gaita D; Latkovskis G; Mazidi M; Toth PP; Pella D; Alnouri F; Postadzhiyan A; Yeh HI; Mancini GBJ; von Haehling S; Banach M; J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1596-1622. PubMed ID: 35969116 [TBL] [Abstract][Full Text] [Related]
49. Pleiotropic effects of metformin to rescue statin-induced muscle injury and insulin resistance: A proposed mechanism and potential clinical implications. Carris NW; Tipparaju SM; Magness DJ; Chapalamadugu KC; Magness RR Med Hypotheses; 2017 Sep; 107():39-44. PubMed ID: 28915960 [TBL] [Abstract][Full Text] [Related]
50. The effects of statins on exercise and physical activity. Noyes AM; Thompson PD J Clin Lipidol; 2017; 11(5):1134-1144. PubMed ID: 28807461 [TBL] [Abstract][Full Text] [Related]
51. Statin-associated incident diabetes: a literature review. Park ZH; Juska A; Dyakov D; Patel RV Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689 [TBL] [Abstract][Full Text] [Related]
52. The Influence of Side Effect Information Framing on Nocebo Effects. Faasse K; Huynh A; Pearson S; Geers AL; Helfer SG; Colagiuri B Ann Behav Med; 2019 Jun; 53(7):621-629. PubMed ID: 30204841 [TBL] [Abstract][Full Text] [Related]
53. Optimizing Cholesterol Treatment in Patients With Muscle Complaints. Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793 [TBL] [Abstract][Full Text] [Related]
55. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events. Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766 [TBL] [Abstract][Full Text] [Related]
56. Muscle- and skeletal-related side-effects of statins: tip of the iceberg? Auer J; Sinzinger H; Franklin B; Berent R Eur J Prev Cardiol; 2016 Jan; 23(1):88-110. PubMed ID: 25230981 [TBL] [Abstract][Full Text] [Related]
57. Statins may increase diabetes, but benefit still outweighs risk. Hoogwerf BJ Cleve Clin J Med; 2023 Jan; 90(1):53-62. PubMed ID: 36596598 [TBL] [Abstract][Full Text] [Related]
58. Progression of precision statin prescribing for reduction of statin-associated muscle symptoms. Petry NJ; Baye JF; Frear S; Jacobsen K; Massmann A; Schultz A; Heukelom JV; Christensen K Pharmacogenomics; 2022 Jul; 23(10):585-596. PubMed ID: 35775396 [No Abstract] [Full Text] [Related]
59. Statin-induced myopathy: the two faces of Janus. Arora R; Liebo M; Maldonado F J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):105-12. PubMed ID: 16891287 [TBL] [Abstract][Full Text] [Related]
60. Increasing and dampening the nocebo response following medicine-taking: A randomised controlled trial. MacKrill K; Morrison Z; Petrie KJ J Psychosom Res; 2021 Nov; 150():110630. PubMed ID: 34607238 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]